Employees: NN (None)Legal category: 5470Size: PMECreation date: 2015-05-11 (11 years)Status: ActiveBusiness sector: Fonds de placement et entités financières similairesLocation: FONDETTES (37230), Indre-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE : revenue, balance sheet and financial ratios
ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE is a French company
founded 11 years ago,
specialized in the sector Fonds de placement et entités financières similaires.
Based in FONDETTES (37230),
this company of category PME
shows in 2025 a net income positive of 169 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE (SIREN 810982280)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
168 606 €
188 590 €
2 074 €
222 484 €
-2 358 €
-2 915 €
186 076 €
24 140 €
91 775 €
-4 992 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
-2 260 €
-4 302 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE generates positive net income of 169 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
168 606 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 91%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6.306%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
91.428%
Solvency indicators evolution ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
65.748
40.536
33.205
20.545
14.227
9.506
3.596
4.032
12.363
6.306
Financial autonomy
60.333
71.156
75.072
82.957
85.28
91.319
93.061
96.124
84.351
91.428
Repayment capacity
-60.363
2.427
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
6.312025
2023
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Good
In 2025, the debt ratio of ABPHARM, SPFPL DE PHARMAC... (6.31) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
91.43%2025
2023
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Excellent
In 2025, the financial autonomy of ABPHARM, SPFPL DE PHARMAC... (91.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1203.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1203.399
Liquidity indicators evolution ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
None
17989.139
33741.525
None
709.021
None
861.678
None
746.918
1203.399
Interest coverage
-109.112
-181.46
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
1203.42025
2024
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Good+5 pts over 2 years
In 2025, the liquidity ratio of ABPHARM, SPFPL DE PHARMAC... (1203.40) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE in its sector
Comparison with sector Fonds de placement et entités financières similaires
Valuation estimate
Based on 170 transactions of similar company sales
(all years),
the value of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE is estimated at
1 747 904 €
(range 1 083 446€ - 2 718 542€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
170 transactions
1083k€1747k€2718k€
1 747 904 €Range: 1 083 446€ - 2 718 542€
NAF 5 all-time
Valuation method used
Net Income Multiple
168 606 €
×
10.4x
=1 747 905 €
Range: 1 083 447€ - 2 718 543€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fonds de placement et entités financières similaires)
Compare ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE with other companies in the same sector:
Frequently asked questions about ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE
What is the revenue of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE ?
The revenue of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE is not publicly disclosed (confidential accounts filed with INPI).
Is ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE profitable?
Yes, ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE generated a net profit of 169 k€ in 2025.
Where is the headquarters of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE ?
The headquarters of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE is located in FONDETTES (37230), in the department Indre-et-Loire.
Where to find the tax return of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE ?
The tax return of ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE operate?
ABPHARM, SPFPL DE PHARMACIEN D'OFFICINE operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart